至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Shaping Substrate Selectivity in a Broad-Spectrum Metallo-β-Lactamase.

Antimicrob. Agents Chemother.. 2018; 
GonzálezLisandro J,StivalCintia,PuzzoloJuan L,MorenoDiego M,VilaAlejand
Products/Services Used Details Operation
PCR Cloning and Subcloning The nucleotidic sequence of blaSPM-1/Sfh-I was synthesized by Genscript (USA) and PCR amplified with primers SPM-1NdeI-Fw (5′- GTACGTCATATGAATTCACCTAAATCGAGAGC-3′) and SPM-1StHindIII-Rv (5′- GTACGTAAGCTTCTACTTTTCGAATTGTGGGTGAGACCACAGTCTCATTTCGCCAAC 3′) for subcloning into pMBLe-blaSPM-1 plasmid (7) through NdeI and HindIII sites. Get A Quote

摘要

Metallo-β-lactamases (MBLs) are the major group of carbapenemases produced by bacterial pathogens. The design of MBL inhibitors has been limited by, among other issues, incomplete knowledge about how these enzymes modulate substrate recognition. While most MBLs are broad-spectrum enzymes, B2 MBLs are exclusive carbapenemases. This narrower substrate profile has been attributed to a sequence insertion present in B2 enzymes that limits accessibility to the active site. In this work, we evaluate the role of sequence insertions naturally occurring in the B2 enzyme Sfh-I and in the broad-spectrum B1 enzyme SPM-1. We engineered a chimeric protein in which the sequence insertion of SPM-1 was replaced by the o... More

关键词

SPM-1,beta-lactamases,mechanisms of resistance,metallo-beta-lactamase,substrate pro